comparemela.com

Latest Breaking News On - Eva bauer raimund gabriel - Page 1 : comparemela.com

Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

28.03.2022 Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron | Atriva | COVID-19 | Omicron | variants

Atriva receives FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics to take part in upcoming scientific and industry conferences in early 2022

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding

DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding 21.04.2021 / 16:03 Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding German Federal Ministry of Education and Research (BMBF) awards Atriva up to €11.4 million for the clinical development of a drug to treat COVID-19 Product candidate ATR-002 could help hospital patients with COVID-19 avoid ventilation and intensive care treatment Targeting RNA viruses and acting in the host cell, drug candidate can retain full activity even with SARS-CoV-2 variants Therapeutic aims to inhibit replication of virus and to prevent overshooting immune response

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.